Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tae-Gyun Woo

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cell Death & Disease|February 8, 2019
p53 induces senescence through Lamin A/C stabilization-mediated nuclear deformationMin-Ho Yoon, So-Mi Kang, Su-Jin Lee, et al.
Molecular Cancer Research : MCR|March 17, 2018
Therapeutic Effect of Quinacrine, an Antiprotozoan Drug, by Selective Suppression of p-CHK1/2 in p53-Negative Malignant CancersSoyoung Park, Ah-Young Oh, Jung-Hyun Cho, et al.
ACS Omega|August 29, 2019
Adsorption and Oxidative Desorption of Acetaldehyde over Mesoporous Fe <i></i> O <i></i> H <i></i> /Al<sub>2</sub>O<sub>3</sub>Jae Hwan Jeong, Soong Yeon Kim, Jeonghun Kim, et al.
Cells|May 13, 2023
Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson-Gilford Progeria SyndromeSo-Mi Kang, Seungwoon Seo, Eun Ju Song, et al.
Molecular Cancer Therapeutics|August 24, 2018
Loss of NF2 Induces TGFβ Receptor 1-mediated Noncanonical and Oncogenic TGFβ Signaling: Implication of the Therapeutic Effect of TGFβ Receptor 1 Inhibitor on NF2 SyndromeJung-Hyun Cho, Ah-Young Oh, Soyoung Park, et al.
Scientific Reports|April 28, 2021
Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin ASo-Mi Kang, Min-Ho Yoon, Su-Jin Lee, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 7, 2025
Size-Dependent Ultrafast UV Photochemistry of Aliphatic Disulfides in SolutionJessica Harich, Rory Ma, Miguel Ochmann, et al.
Molecular Therapy. Oncology|October 1, 2024
The therapeutic effect of DX2 inhibition in nicotine-induced lung cancer progressionSoyoung Park, Ah-Young Oh, Byung-Su Hong, et al.
Communications Biology|December 16, 2021
Novel chemical inhibitor against SOD1 misfolding and aggregation protects neuron-loss and ameliorates disease symptoms in ALS mouse modelTae-Gyun Woo, Min-Ho Yoon, So-Mi Kang, et al.
Translational Neurodegeneration|May 11, 2025
Inhibition of SOD1 trimerization is a novel drug target for ALS diseaseTae-Gyun Woo, Jin Han, Yuju Kim, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cell Death & Disease|February 8, 2019
p53 induces senescence through Lamin A/C stabilization-mediated nuclear deformationMin-Ho Yoon, So-Mi Kang, Su-Jin Lee, et al.
Molecular Cancer Research : MCR|March 17, 2018
Therapeutic Effect of Quinacrine, an Antiprotozoan Drug, by Selective Suppression of p-CHK1/2 in p53-Negative Malignant CancersSoyoung Park, Ah-Young Oh, Jung-Hyun Cho, et al.
ACS Omega|August 29, 2019
Adsorption and Oxidative Desorption of Acetaldehyde over Mesoporous Fe <i></i> O <i></i> H <i></i> /Al<sub>2</sub>O<sub>3</sub>Jae Hwan Jeong, Soong Yeon Kim, Jeonghun Kim, et al.
Cells|May 13, 2023
Progerinin, an Inhibitor of Progerin, Alleviates Cardiac Abnormalities in a Model Mouse of Hutchinson-Gilford Progeria SyndromeSo-Mi Kang, Seungwoon Seo, Eun Ju Song, et al.
Molecular Cancer Therapeutics|August 24, 2018
Loss of NF2 Induces TGFβ Receptor 1-mediated Noncanonical and Oncogenic TGFβ Signaling: Implication of the Therapeutic Effect of TGFβ Receptor 1 Inhibitor on NF2 SyndromeJung-Hyun Cho, Ah-Young Oh, Soyoung Park, et al.
Scientific Reports|April 28, 2021
Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin ASo-Mi Kang, Min-Ho Yoon, Su-Jin Lee, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 7, 2025
Size-Dependent Ultrafast UV Photochemistry of Aliphatic Disulfides in SolutionJessica Harich, Rory Ma, Miguel Ochmann, et al.
Molecular Therapy. Oncology|October 1, 2024
The therapeutic effect of DX2 inhibition in nicotine-induced lung cancer progressionSoyoung Park, Ah-Young Oh, Byung-Su Hong, et al.
Communications Biology|December 16, 2021
Novel chemical inhibitor against SOD1 misfolding and aggregation protects neuron-loss and ameliorates disease symptoms in ALS mouse modelTae-Gyun Woo, Min-Ho Yoon, So-Mi Kang, et al.
Translational Neurodegeneration|May 11, 2025
Inhibition of SOD1 trimerization is a novel drug target for ALS diseaseTae-Gyun Woo, Jin Han, Yuju Kim, et al.
Pageof 3